Ambrx Biopharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ambrx Biopharma generated cash of -$68,675,000, which is less than the previous year. Cash used in financing activities reached the amount of $928,000 last year. Net change in cash is therefore -$114,465,000.
Cash Flow
| 2019 | -2.76M | -48K | 0 |
|---|---|---|---|
| 2020 | -20.57M | -252K | 95.67M |
| 2021 | -44.64M | -3.20M | 127.42M |
| 2022 | -68.67M | -46.71M | 928K |
AMAM Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 170.90M | 91.27M | 16.26M | 19.11M |
Operating activities | ||||
Net income | -77.99M | -68.28M | -17.83M | -22.31M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 1.80M | 2.15M | 1.94M | 2.05M |
Stock-based compensation expense | 6.25M | 11.85M | 1.21M | 1.83M |
| Deferred income tax benefit | 6.25M | 11.85M | 1.21M | 1.83M |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 863K | -811K | 415K | -762K |
Inventories | 0 | 6.13M | -3.26M | 151K |
Accounts payable | -1.82M | 2.40M | -3.24M | 3.77M |
Cash generated by operating activities | -68.67M | -44.64M | -20.57M | -2.76M |
Investing activities | ||||
Purchases Of Investments | -84.85M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.05M | -3.20M | -252K | -48K |
Acquisitions Net | 45.66M | 0 | 0 | 0 |
Cash generated by investing activities | -46.71M | -3.20M | -252K | -48K |
Financing activities | ||||
Common Stock Issued | 0 | 148.73M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -1.33M | 0 |
Cash used in financing activities | 928K | 127.42M | 95.67M | 0 |
Net Change In Cash | -114.46M | 79.62M | 75.01M | -2.85M |
Cash at end of period | 56.44M | 170.90M | 91.27M | 16.26M |
| Data source | Data source |